Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223

NCT03223597 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic
Bone Metastases

Interventions

DRUG: Radium-223 dichloride

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]